Petco Health & Wellness Company, Inc. — Form 10-Q Summary
Reporting period: The filing covers the 13 and 39 weeks ended October 28, 2023, compared with periods ended October 29, 2022. The request metadata says “2022 Q3,” but the filing itself is for fiscal 2023 Q3.
Business context and results
Petco operates an omnichannel pet products and services business, including grooming and veterinary care, and reports as one operating segment. At quarter-end it reported 1,429 pet care centers and 282 veterinary practices.
| Metric | Q3 2023 | Q3 2022 | 39 weeks 2023 | 39 weeks 2022 |
|---|---|---|---|---|
| Net sales | $1,494.2 million | $1,501.2 million | $4,580.8 million | $4,458.0 million |
| Gross profit / margin | $550.0 million / 36.8% | $597.7 million / 39.8% | $1,747.5 million / 38.1% | $1,799.8 million / 40.4% |
| Operating income (loss) | $(1,232.1) million | $48.1 million | $(1,180.5) million | $148.0 million |
| Net income (loss) attributable to common stockholders | $(1,241.1) million | $19.9 million | $(1,257.6) million | $58.1 million |
| Adjusted EBITDA / margin | $72.2 million / 4.8% | $120.2 million / 8.0% | $295.8 million / 6.5% | $372.9 million / 8.4% |
Material changes and management commentary
- Quarterly sales declined 0.5%; comparable sales were flat. For the 39 weeks, sales rose 2.8% and comparable sales rose 2.8%.
- Q3 product sales fell 2.9%, including an 8.8% decline in supplies and companion animals; consumables rose 1.8%. Services and other increased 15.0%, supported by grooming, veterinary activity, and membership offerings. Digital sales increased 4.7% in the quarter.
- Management attributed weaker discretionary-category demand to inflationary pressures and softer consumer spending. It cited consumables and services as areas of momentum.
- Gross margin declined year over year, which management attributed primarily to product and channel mix, including higher consumables and softer supplies sales, and investment in expanding the consumables assortment.
- Adjusted EBITDA fell to $72.2 million in Q3 from $120.2 million. Management cited investments in infrastructure and people and higher equity compensation among SG&A factors; lower advertising partly offset YTD SG&A increases.
Impairment, cash flow, debt, and liquidity
- A noncash goodwill impairment charge of $1,222.5 million was recorded in Q3 after declines in the share price and macroeconomic conditions triggered an interim test. Goodwill fell from $2,193.9 million at fiscal year-end to $976.2 million. The trade name was tested and was not impaired. The goodwill valuation used Level 3 assumptions, including a 16.4% discount rate and 3% terminal growth rate.
- For the 39 weeks, operating cash flow was $168.7 million, down from $209.5 million. Capital spending was $176.5 million; reported free cash flow was negative $7.8 million, compared with negative $2.6 million a year earlier. Cash, cash equivalents, and restricted cash declined $71.5 million to $142.2 million.
- At October 28, cash and cash equivalents were $139.8 million. Liquidity was reported as $586.4 million, including $446.6 million available under the ABL revolving facility. Current assets of $1,007.5 million were below current liabilities of $1,114.6 million.
- First Lien Term Loan principal was $1,595.3 million, with a weighted average interest rate of 9.0%; no ABL borrowings were outstanding. Petco made $75 million of voluntary term-loan repayments during the 39 weeks. Interest expense increased to $111.3 million from $68.8 million, primarily due to higher rates. The company reported covenant compliance.
- Management said available resources, anticipated operating cash flow, and revolver capacity should fund operations, current cash needs, and anticipated capital investments for at least the next 12 months. This is not formal earnings guidance. The filing notes that future financing may be sought, but availability and terms are uncertain.
Risks, contingencies, and other disclosures
- Key risks include inflation, interest-rate and consumer-spending pressures, competition, vendor and supply-chain reliance, labor and operating costs, technology and cybersecurity, and the ability to execute cost and operational initiatives. Petco warned that further goodwill or intangible-asset impairments could adversely affect results.
- Interest-rate caps and collars hedge part of variable-rate exposure. Petco estimated that a 100-basis-point increase in variable rates would raise annual cash interest by approximately $16.2 million, before considering the effect of hedges.
- Petco is involved in ordinary-course legal matters. Management did not expect them to have a material adverse effect, while noting outcomes are uncertain and some losses are not accrued because they are not considered probable or estimable.
- Management concluded disclosure controls were effective at a reasonable-assurance level; no material change in internal control over financial reporting was reported.
Important facts for investors to verify
- Whether sales trends, comparable sales, and discretionary-category demand improve or deteriorate after the reported quarter.
- Whether gross margin and Adjusted EBITDA stabilize, and how much further investment or cost action affects performance.
- The assumptions behind the goodwill valuation and the possibility of additional impairment, including for other intangible assets.
- Cash generation, inventory and working-capital needs, capital spending, and continued access to the ABL facility.
- Variable-rate debt costs, hedge coverage, covenant headroom, and the company’s ability to meet obligations as rates and operating conditions change.